August 22, 2017 5:33 PM ET


Company Overview of Oncos Therapeutics Ltd

Company Overview

Oncos Therapeutics Ltd., a clinical-stage biotechnology company, develops and commercializes targeted cancer immunotherapy products. It offers ONCOS-102, an engineered human serotype 5 adenovirus optimized to induce systemic anti-tumor T cell response in cancer patients. The company also engages in the development of products using its adenovirus-based cancer immunotherapy platform for the treatment of various cancer types, including soft tissue sarcoma, ovarian cancer, and mesothelioma. Oncos Therapeutics Ltd. was founded in 2009 and is based in Helsinki, Finland. As of July 2, 2015, Oncos Therapeutics Ltd operates as a subsidiary of Targovax AS.

Saukonpaadenranta 2

Helsinki,  00180


Founded in 2009


358 4073 00445


358 9856 57321

Key Executives for Oncos Therapeutics Ltd

Co-Founder and Chief Operating Officer
Head of Clinical Science
Vice President Strategy Via Lifeline Ventures
Research Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Arctic Diagnostics Oy Europe
Aurealis Oy Europe
Biovian Oy Europe
Bioxid Ltd Oy Europe
Blueprint Genetics Oy Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncos Therapeutics Ltd, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at